Treatment with the anti-IgE monoclonal antibody omalizumab in women with asthma undergoing fertility treatment: a proof-of-concept study—The PRO-ART study protocol
Introduction Asthma is associated with prolonged time to pregnancy and a higher need for fertility treatment. However, the mechanism underlying this association remains incompletely understood. Previous research points to asthma-driven systemic inflammation also affecting the reproductive organs and...
Saved in:
| Main Authors: | Karsten Kristiansen, Nina La Cour Freiesleben, Charlotte Suppli Ulrik, Henriette Svarre Nielsen, Casper Tidemandsen, Elisabeth Juul Gade, Birgitte Sophie Oxlund-Mariegaard, Bugge Nøhr, Hanne Udengaard, Vibeke Backer |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2020-11-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/10/11/e037041.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advances in omalizumab treatment for IgE-mediated food allergies
by: Siqi WANG, et al.
Published: (2025-08-01) -
Efficacy of Omalizumab Therapy in an Asthmatic with Low IgE
by: Divya R, et al.
Published: (2020-01-01) -
Critical pathomechanisms of NSAID-exacerbated respiratory disease (N-ERD) clarified by treatment with omalizumab, an anti-IgE antibody
by: Hiroaki Hayashi, et al.
Published: (2025-01-01) -
OMALIZUMAB IN TREATMENT FOR ALLERGIES
by: T.V. Kulichenko
Published: (2007-08-01) -
Four-week IgE/baseline IgE ratio combined with tryptase predicts clinical outcome in omalizumab-treated children with moderate-to-severe asthma
by: Lu Min, et al.
Published: (2025-05-01)